Logo image of SCR.PA

SCOR SE (SCR.PA) Stock Fundamental Analysis

EPA:SCR - Euronext Paris - Matif - FR0010411983 - Common Stock - Currency: EUR

28.07  +0.47 (+1.7%)

Fundamental Rating

3

Overall SCR gets a fundamental rating of 3 out of 10. We evaluated SCR against 40 industry peers in the Insurance industry. Both the profitability and financial health of SCR have multiple concerns. SCR is valued correctly, but it does not seem to be growing. Finally SCR also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

SCR had positive earnings in the past year.
In the past year SCR had a positive cash flow from operations.
Of the past 5 years SCR 4 years were profitable.
In the past 5 years SCR always reported a positive cash flow from operatings.
SCR.PA Yearly Net Income VS EBIT VS OCF VS FCFSCR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

SCR has a worse Return On Assets (0.22%) than 82.50% of its industry peers.
SCR has a worse Return On Equity (1.83%) than 82.50% of its industry peers.
With a Return On Invested Capital value of 1.27%, SCR perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
Industry RankSector Rank
ROA 0.22%
ROE 1.83%
ROIC 1.27%
ROA(3y)-0.63%
ROA(5y)-0.1%
ROE(3y)-4.88%
ROE(5y)-0.74%
ROIC(3y)N/A
ROIC(5y)N/A
SCR.PA Yearly ROA, ROE, ROICSCR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

The Profit Margin of SCR (0.35%) is worse than 85.00% of its industry peers.
In the last couple of years the Profit Margin of SCR has declined.
SCR has a worse Operating Margin (2.70%) than 85.00% of its industry peers.
In the last couple of years the Operating Margin of SCR has declined.
Industry RankSector Rank
OM 2.7%
PM (TTM) 0.35%
GM N/A
OM growth 3Y-19.97%
OM growth 5Y-12.19%
PM growth 3Y-78.6%
PM growth 5Y-60.26%
GM growth 3YN/A
GM growth 5YN/A
SCR.PA Yearly Profit, Operating, Gross MarginsSCR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SCR is destroying value.
SCR has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for SCR has been reduced compared to 5 years ago.
SCR has a worse debt/assets ratio than last year.
SCR.PA Yearly Shares OutstandingSCR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SCR.PA Yearly Total Debt VS Total AssetsSCR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

SCR has a debt to FCF ratio of 4.06. This is a neutral value as SCR would need 4.06 years to pay back of all of its debts.
SCR has a Debt to FCF ratio (4.06) which is in line with its industry peers.
A Debt/Equity ratio of 0.78 indicates that SCR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.78, SCR is doing worse than 72.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 4.06
Altman-Z N/A
ROIC/WACC0.22
WACC5.77%
SCR.PA Yearly LT Debt VS Equity VS FCFSCR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SCR.PA Yearly Current Assets VS Current LiabilitesSCR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

SCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -98.81%.
The earnings per share for SCR have been decreasing by -57.79% on average. This is quite bad
Looking at the last year, SCR shows a decrease in Revenue. The Revenue has decreased by -3.25% in the last year.
The Revenue has been decreasing by -0.88% on average over the past years.
EPS 1Y (TTM)-98.81%
EPS 3Y-76.98%
EPS 5Y-57.79%
EPS Q2Q%1.82%
Revenue 1Y (TTM)-3.25%
Revenue growth 3Y-3.61%
Revenue growth 5Y-0.88%
Sales Q2Q%-0.91%

3.2 Future

Based on estimates for the next years, SCR will show a very strong growth in Earnings Per Share. The EPS will grow by 170.11% on average per year.
Based on estimates for the next years, SCR will show a small growth in Revenue. The Revenue will grow by 3.02% on average per year.
EPS Next Y13484.5%
EPS Next 2Y1117.07%
EPS Next 3Y444.4%
EPS Next 5Y170.11%
Revenue Next Year2.59%
Revenue Next 2Y2.62%
Revenue Next 3Y3.02%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SCR.PA Yearly Revenue VS EstimatesSCR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
SCR.PA Yearly EPS VS EstimatesSCR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 561.40, the valuation of SCR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SCR indicates a rather expensive valuation: SCR more expensive than 87.50% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SCR to the average of the S&P500 Index (26.86), we can say SCR is valued expensively.
SCR is valuated cheaply with a Price/Forward Earnings ratio of 6.32.
SCR's Price/Forward Earnings ratio is rather cheap when compared to the industry. SCR is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.43, SCR is valued rather cheaply.
Industry RankSector Rank
PE 561.4
Fwd PE 6.32
SCR.PA Price Earnings VS Forward Price EarningsSCR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400 500

4.2 Price Multiples

SCR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SCR is cheaper than 90.00% of the companies in the same industry.
SCR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SCR is cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.75
EV/EBITDA 7.08
SCR.PA Per share dataSCR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SCR's earnings are expected to grow with 444.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y1117.07%
EPS Next 3Y444.4%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.43%, SCR is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.54, SCR pays a better dividend. On top of this SCR pays more dividend than 92.50% of the companies listed in the same industry.
SCR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 6.43%

5.2 History

The dividend of SCR has a limited annual growth rate of 0.57%.
Dividend Growth(5Y)0.57%
Div Incr Years1
Div Non Decr Years1
SCR.PA Yearly Dividends per shareSCR.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SCR pays out 390.36% of its income as dividend. This is not a sustainable payout ratio.
The dividend of SCR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP390.36%
EPS Next 2Y1117.07%
EPS Next 3Y444.4%
SCR.PA Yearly Income VS Free CF VS DividendSCR.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B
SCR.PA Dividend Payout.SCR.PA Dividend Payout, showing the Payout Ratio.SCR.PA Dividend Payout.PayoutRetained Earnings

SCOR SE

EPA:SCR (6/27/2025, 4:47:58 PM)

28.07

+0.47 (+1.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners47.28%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap5.03B
Analysts76.84
Price Target31.2 (11.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.43%
Yearly Dividend1.81
Dividend Growth(5Y)0.57%
DP390.36%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-86.77%
Min EPS beat(2)-182.14%
Max EPS beat(2)8.6%
EPS beat(4)1
Avg EPS beat(4)-115.73%
Min EPS beat(4)-282.85%
Max EPS beat(4)8.6%
EPS beat(8)3
Avg EPS beat(8)-46.59%
EPS beat(12)4
Avg EPS beat(12)-136.91%
EPS beat(16)8
Avg EPS beat(16)-50.62%
Revenue beat(2)2
Avg Revenue beat(2)5.21%
Min Revenue beat(2)2.78%
Max Revenue beat(2)7.63%
Revenue beat(4)4
Avg Revenue beat(4)5.45%
Min Revenue beat(4)2.78%
Max Revenue beat(4)7.84%
Revenue beat(8)8
Avg Revenue beat(8)5.76%
Revenue beat(12)12
Avg Revenue beat(12)22.78%
Revenue beat(16)15
Avg Revenue beat(16)33.58%
PT rev (1m)2.65%
PT rev (3m)11.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.36%
Revenue NQ rev (1m)2.28%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.39%
Valuation
Industry RankSector Rank
PE 561.4
Fwd PE 6.32
P/S 0.21
P/FCF 5.75
P/OCF 5.58
P/B 1.11
P/tB 1.58
EV/EBITDA 7.08
EPS(TTM)0.05
EY0.18%
EPS(NY)4.44
Fwd EY15.83%
FCF(TTM)4.88
FCFY17.38%
OCF(TTM)5.03
OCFY17.94%
SpS132.27
BVpS25.22
TBVpS17.78
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.22%
ROE 1.83%
ROCE 1.73%
ROIC 1.27%
ROICexc 1.36%
ROICexgc 1.65%
OM 2.7%
PM (TTM) 0.35%
GM N/A
FCFM 3.69%
ROA(3y)-0.63%
ROA(5y)-0.1%
ROE(3y)-4.88%
ROE(5y)-0.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-11.91%
ROICexcg growth 5Y-6.82%
ROICexc growth 3Y-13.22%
ROICexc growth 5Y-8.16%
OM growth 3Y-19.97%
OM growth 5Y-12.19%
PM growth 3Y-78.6%
PM growth 5Y-60.26%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 4.06
Debt/EBITDA 4.08
Cap/Depr 12.56%
Cap/Sales 0.12%
Interest Coverage 6.21
Cash Conversion 104.64%
Profit Quality 1054.22%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC5.77%
ROIC/WACC0.22
Cap/Depr(3y)19.46%
Cap/Depr(5y)36.14%
Cap/Sales(3y)0.27%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.81%
EPS 3Y-76.98%
EPS 5Y-57.79%
EPS Q2Q%1.82%
EPS Next Y13484.5%
EPS Next 2Y1117.07%
EPS Next 3Y444.4%
EPS Next 5Y170.11%
Revenue 1Y (TTM)-3.25%
Revenue growth 3Y-3.61%
Revenue growth 5Y-0.88%
Sales Q2Q%-0.91%
Revenue Next Year2.59%
Revenue Next 2Y2.62%
Revenue Next 3Y3.02%
Revenue Next 5YN/A
EBIT growth 1Y-72.09%
EBIT growth 3Y-22.86%
EBIT growth 5Y-12.97%
EBIT Next Year307.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.53%
FCF growth 3Y-27.74%
FCF growth 5Y4.24%
OCF growth 1Y-38.99%
OCF growth 3Y-27.87%
OCF growth 5Y1.43%